Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Matthew Kurian

Breast Oncology · St Elizabeth Healthcare

View

Dr. Sarah Premji

Breast Oncology

View

Dr. Roberto Leon-Ferre

Breast Oncology · Mayo Clinic College of Medicine

View

Dr. Nerea Lopetegui-Lia

Breast Oncology · OSUMC

View

Dr. Allison Kurian

Breast Oncology · SU

View

Dr. Minhtri Nguyen

Breast Oncology · Advisor

View

Dr. Neil Iyengar

Breast Oncology · Emory University

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JMDr. Jason Mouabbi
    Leading Voice

    Dr. Jason Mouabbi

    Medical Oncology · Breast Oncology
    The University of Texas MD Anderson Cancer Center
    jasonm

    Research

    Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer.

    2025

    Via Clinical Cancer Research

    Research

    Clinical Characteristics and Survival Outcomes of Metastatic Invasive Lobular and Ductal Carcinoma.

    2025

    Via JAMA Network Open

    May 2, 2025Journal Article

    Characterization of the Germline Pathogenic Mutational Landscape and Oncologic Outcomes Among 877 Patients with Invasive Lobular Carcinoma.

    ​

    Written by 1 Roon author & 9 others

    Via Annals of Surgical Oncology

    Research

    Immediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situ.

    2025

    Via Breast Cancer Research and Treatment

    Research

    Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserving Surgery.

    2025

    Via International Journal of Radiation Oncology, Biology, Physics

    Research

    Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study.

    2025

    Via Breast Cancer Research

    Research

    Impact of concurrent lobular carcinoma in situ on recurrence outcomes in patients with classic and pleomorphic invasive lobular carcinoma of the breast.

    2025

    Via Breast Cancer Research and Treatment

    Research

    Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma.

    2024

    Via The Oncologist

    Research

    Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-F-Fluoro-17β-Fluoroestradiol.

    2023

    Via Journal of Nuclear Medicine

    Research

    Survival Outcomes in Patients With Hormone Receptor-Positive Metastatic Breast Cancer With Low or No ERBB2 Expression Treated With Targeted Therapies Plus Endocrine Therapy.

    2023

    Via JAMA Network Open

    Research

    Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma.

    2023

    Via European Journal of Cancer

    Research

    Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights.

    2023

    Via Cancers

    Research

    Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.

    2022

    Via Breast Cancer Research and Treatment

    Research

    Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies.

    2022

    Via NPJ Breast Cancer

    Research

    Lumpectomy followed by radiation improves survival in HER2 positive and triple-negative breast cancer with high tumor-infiltrating lymphocytes compared to mastectomy alone.

    2021

    Via Cancer Medicine